Tech
Health Kick: New ASX listee Audeara uses algorithms to create perfect audio and better hearing health
Health & Biotech
Health Kick: Injectable contrast dyes have serious health impacts, Osprey Medical has the solution
Health & Biotech
Health Kick: CEO Rob Wong on how Control Bionics is enabling communication via brain signals
Health & Biotech
HealthKick Podcast: Kazia tackles the curse of US politicians with its innovative drug candidate
Health & Biotech
HealthKick Podcast: Dr Chris Behrenbruch on taking Telix Pharma to $1bn and the future of nuclear medicine
Health & Biotech
Health Kick: Renowned biotech entrepreneur Paul Hopper on raising money, picking biotech winners and his latest ASX venture
Health & Biotech
HealthKick Podcast: NSB brings new solutions to medicine’s most stubborn eye problems
Health & Biotech
Healthkick Podcast: Neuren is cashed up, confident and charging into a phase 3 trial
Health & Biotech
Health Kick Podcast: Osteopore’s expansion plans and new markets after 2019’s stellar IPO
Health & Biotech
Health Kick: Investors eye AdAlta’s fibrosis fighting i-body platform
Health & Biotech
Health Kick Podcast: Investors smell success in Rhinomed’s flu and coronavirus nasal swab technology
Health & Biotech
Health Kick Podcast: This biopharma company may be the world’s only exosome-based player
Health & Biotech
Health Kick Podcast: Investors love Apiam’s diversified pet and livestock vet offering
Health & Biotech
Health Kick Podcast: PainChek’s AI-backed pain assessment tech a game-changer for treating infants and the elderly
Health & Biotech
Health Kick Podcast: Investors still high on Incannex cannabinoid pivot and COVID-19 treatment news
Health & Biotech
Health Kick Podcast: Starpharma goes from strength to strength following news of progress on COVID-19 nasal spray
Health & Biotech
Health Kick Podcast: Cannpal has first mover advantage in the $67bn “hidden gem” animal health market
Health & Biotech
Health Kick Podcast: Chemo’s diminishing role, the ‘personalised’ approach to cancer treatment and PTX’s CAR-T innovations
Health & Biotech
Health Kick: Zelira’s cannabis-derived insomnia treatment has investors dreaming
Health & Biotech
Health Kick Podcast: Botanix is using synthetic cannabinoids to treat acne and other skin conditions
Health & Biotech
Health Kick: Pancreatic cancer treater OncoSil continues impressive bounce-back
Health & Biotech
Health Kick: This drug developer is up 200pc following inclusion in a COVID-19 related trial
Health & Biotech
Health Kick: Cynata’s stem cell therapy could be a game changer for COVID-19 patients
Health & Biotech
Health Kick: This stock has a clear vision for the future of contact lenses
Health & Biotech
Health Kick Podcast: Accurately measuring cognition offers massive upside to clinicians and drug makers; CGS has the tech
Health & Biotech
Health Kick Podcast: Can listed Aussie drug makers survive COVID-19?
Health & Biotech
Health Kick podcast: Chronic kidney disease is a worldwide health crisis, ASX-listed DXB is driving improved treatment
Health & Biotech
Health Kick Podcast: Increasing athletic performance and fighting sleep apnea with a simple nose clip
Health & Biotech
Health Kick Podcast: Understanding immunotherapy, why the drug market dried up and Immutep’s profitable potential
Health & Biotech
Health Kick Podcast: Memphasys is using electrical forces on sperm to get better IVF results
Food & Agriculture
Health Kick Podcast: The strategy and upside behind global cannabis investment company MMJ
Health & Biotech
Health Kick Podcast: Could oral sprays replace pills as a better means of drug delivery?
Food & Agriculture
Health Kick Podcast: The ASX’s only medicinal honey player and the advantage of Amazon-aided US exposure
Health & Biotech
Health Kick Podcast: Skyrocketing prescription prices and Trump’s plan for the drug market
Health & Biotech
Health Kick Podcast: Coronavirus, HIV and hepatitis are in the sights of Aussie biotech Biotron
Health & Biotech
Health Kick Podcast: Novel gene targeting therapies, protein disruptors and why ANP’s recent trial success have investors buzzing
Health & Biotech
Health Kick Podcast: Learning from the Swine flu pandemic, the market potential of exosome therapeutics and jumping ASX life-sciences hurdles
Health & Biotech
Health Kick Podcast: Commercialising orphan drugs, the need for better regulation and the ASX’s lifestyle play problem
Health & Biotech
Health Kick Podcast: The science behind 2019’s hottest IPO and the company’s plans for 2020
Health & Biotech
Health Kick Podcast: Investing in repurposed drugs, combating intracranial pressure and why Invex caught NASA’s eye
Health & Biotech
Health Kick Podcast: What’s holding back better breast cancer detection? And how is Volpara’s tech changing the game?
Health & Biotech
Health Kick Podcast: Developing drugs, fighting fibrosis and squeezing squishometers
Health & Biotech
Health Kick Podcast: How Aussie health stocks are performing internationally and Prescient’s cancer-blocking innovation
Health & Biotech
Health Kick Podcast: The growth of musculoskeletal disorders, new markets created by ageing populations and OCC’s Avatar moment
Load More
Featured Health Kick Podcast Stocks
Health Kick Podcast
In his weekly “The Health Kick Podcast” Tim will interview Australia’s leading Health and Biotech industry leaders, bringing his own unique insight and perspective into the world of health and drug discovery.
